Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-Label Pediatric Drug Use To Be Tracked Through FDA Database Contracts

Executive Summary

Off-label drug use in pediatric patients will be tracked under FDA contracts for longitudinal prescription data.
Advertisement

Related Content

FDA expands data mining contract
FDA expands data mining contract
FDA, Kaiser Discussing COX-2 Myocardial Infarction Study
FDA, Kaiser Discussing COX-2 Myocardial Infarction Study
FDA Pharmacoepidemiology Office Adding 10 FTEs In CDER Reorganization
FDA Pharmacoepidemiology Office Adding 10 FTEs In CDER Reorganization
FDA Seeking Databases To Track Patient Drug Exposure To NMEs
FDA Seeking Databases To Track Patient Drug Exposure To NMEs
Advertisement
UsernamePublicRestriction

Register

PS038711

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel